
The EU Just Bet $14.4M on Cow-Free Whey Protein
Dutch startup Vivici lands €12.5M from the European Innovation Council, accelerating its precision fermentation whey protein platform beyond Series A momentum.
Public funding is now chasing precision fermentation whey protein. Dutch food tech firm Vivici has secured €12.5M ($14.4M) from the European Innovation Council, less than a year after closing a €32.5M Series A.
TLDR
- EU’s EIC Accelerator commits €12.5M to Vivici’s cow-free protein platform.
- Funding follows a €32.5M Series A raised just one year prior.
- Vivici produces whey protein via precision fermentation, no cows required.
- European public capital is increasingly backing alt-protein infrastructure.
- Operators seeking clean-label dairy protein alternatives have a new supplier to watch.
Dutch startup Vivici has now drawn both private venture capital and European public funding into its corner. Green Queen reports the European Innovation Council (EIC) Accelerator awarded the company €12.5M to scale its animal-free dairy protein operations.
Precision Fermentation Whey Protein Attracts Public Capital
Vivici produces whey protein through precision fermentation, engineering microorganisms to express the same proteins found in cow’s milk. The result is functionally identical whey, with no livestock in the supply chain. For food manufacturers navigating clean-label reformulation, that distinction matters.
The EIC Accelerator is a competitive EU grant-and-equity instrument targeting deep-tech companies. Selection signals institutional confidence, not just commercial interest. Vivici’s win suggests European regulators and innovation bodies view precision fermentation as infrastructure, not a niche.
A Fast Funding Cadence Signals Serious Scale Plans
The timing is notable. Vivici closed its Series A just twelve months ago, pulling in €32.5M from private investors. Stacking €12.5M in public funding on top of that, this quickly, points to an aggressive expansion timeline.
Additionally, EIC backing often unlocks further EU network effects: procurement relationships, regulatory navigation support, and access to pan-European pilot infrastructure. For ingredient suppliers and contract manufacturers watching this space, Vivici’s trajectory is worth tracking closely.
In short, the race to supply animal-free dairy protein to mainstream food manufacturers is accelerating. Vivici is now capitalized to compete at scale. The brands that lock in supplier relationships early will have the cleaner labels when consumer demand peaks.
Source: Green Queen. https://www.greenqueen.com.hk/vivici-european-innovation-council-eic-accelerator-funding-whey-protein/
